Studying cancer in context to stop its growth
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
Through the PKG Public Service Center’s social impact internships, MIT students leverage their analytical, technical, and creative problem-solving skills for public good.
The MIT School of Engineering recently honored outstanding faculty, students, and staff with its 2023 awards.
Nine faculty members have been granted tenure in six units across MIT’s School of Engineering.
MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy.
C16 Biosciences, founded by MIT alumni, has developed a microbial oil to replace palm oil, whose production reaps environmental devastation.